SecurityXIN / Xinyuan Real Estate Co., Ltd. (98417P105)
Institutional Owners56
Institutional Shares12,284,305
Institutional Value$ 64,795,000 USD

Institutional Stock Ownership and Shareholders()

XIN / Xinyuan Real Estate Co., Ltd. Institutional Ownership

Xinyuan Real Estate Co., Ltd. (NYSE:XIN) has 56 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,284,305 shares. Largest shareholders include TPG Group Holdings (SBS) Advisors, Inc., Renaissance Technologies LLC, Ajo, Lp, Prudential Financial Inc, JP Morgan Chase & Co, Susquehanna International Group, Llp, Dimensional Fund Advisors Lp, Two Sigma Advisers, Lp, Susquehanna International Group, Llp, and Group One Trading, L.p..
Xinyuan Real Estate Co., Ltd. (NYSE:XIN) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/xin"><img src="https://images.fintel.io/us-xin-so.png" alt="XIN / Xinyuan Real Estate Co., Ltd. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 9 10 11.11 0 4
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 203,491 277,215 36.23 1,386 1,464 5.63
2018-05-11 13F-HR SEI INVESTMENTS CO 0 700 0 4
2018-05-15 13F-HR BlueCrest Capital Management Ltd 0 11,602 0 61
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 10,500 0 -100.00 72 0 -100.00
2018-05-14 13F-HR Virtu Financial LLC 0 18,738 0 99
2017-10-26 13F-HR Acrospire Investment Management LLC 502 0 -100.00 3 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 182,174 202,453 11.13 1,241 1,069 -13.86
2018-05-10 13F-HR Myda Advisors Llc Call 50,000 0 -100.00 341 0 -100.00
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 1 720 71,900.00 0 4
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 1,607 1,682 4.67 11 8 -27.27
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 443,147 420,652 -5.08 3,018 2,221 -26.41
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 63,389 130,710 106.20 431 690 60.09
2018-05-15 13F-HR Ativo Capital Management LLC 170,053 0 -100.00 1,158 0 -100.00
2018-05-15 13F-HR Invesco Ltd. 76,081 79,417 4.38 518 419 -19.11
2018-05-15 13F-HR WOLVERINE TRADING, LLC 31,167 30,847 -1.03 212 163 -23.11
2018-05-15 13F-HR BARCLAYS PLC 75,620 48,135 -36.35 515 254 -50.68
2018-05-14 13F-HR Renaissance Technologies LLC 1,713,800 1,700,800 -0.76 11,671 8,980 -23.06
2018-05-04 13F-HR PRUDENTIAL FINANCIAL INC 762,664 811,564 6.41 5,194 4,285 -17.50
2018-05-15 13F-HR PEAK6 Investments, L.P. 52,813 32,008 -39.39 360 169 -53.06
2018-05-15 13F-HR STATE STREET CORP 77,800 77,800 0.00 530 412 -22.26
2018-05-17 13F-HR Legal & General Group Plc 5,264 5,264 0.00 36 28 -22.22
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 36,300 45,200 24.52 247 239 -3.24
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 16,415 0 -100.00 112 0 -100.00
2018-05-04 13F-HR Financial Gravity Companies, Inc. 988 0 -100.00 7 0 -100.00
2018-05-11 13F-HR STIFEL FINANCIAL CORP 39,062 21,362 -45.31 254 113 -55.51
2018-05-15 13F-HR UBS Group AG 3,840 4,093 6.59 26 22 -15.38
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 35 347 891.43 5 12 140.00
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 231,700 267,500 15.45 1,578 1,412 -10.52
2018-05-15 13F-HR BARCLAYS PLC Call 2,000 1,800 -10.00 14 10 -28.57
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 25,588 19,974 -21.94 175 105 -40.00
2018-05-14 13F-HR AJO, LP 1,001,239 1,134,230 13.28 6,818 5,989 -12.16
2018-05-15 13F-HR TPG Group Holdings (SBS) Advisors, Inc. 6,000,000 4,596,985 -23.38 40,860 24,272 -40.60
2017-02-10 13F-HR BlackRock Group LTD 20,335 21,819 7.30 129 108 -16.28
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 151,500 204,200 34.79 1,032 1,078 4.46
2018-05-15 13F-HR PEAK6 Investments, L.P. Call 10,000 0 -100.00 68 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 7,066 0 -100.00 48 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 113,700 250,900 120.67 774 1,325 71.19
2018-05-11 13F-HR Cutler Group LP Call 27,600 26,800 -2.90 25 2 -92.00
2018-07-20 13F-HR Steward Partners Investment Advisory, Llc 300 0 -100.00 1 0 -100.00
2018-04-30 13F-HR Advisors Preferred, LLC 13,944 0 -100.00 95 0 -100.00
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 507,127 112,796 -77.76 3,454 596 -82.74
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 15,700 26,600 69.43 107 140 30.84
2018-05-15 13F-HR Wellington Management Group LLP 41,114 60,615 47.43 280 320 14.29
2018-05-15 13F-HR CREDIT SUISSE AG/ 0 11,778 0 62
2018-05-08 13F-HR Aperio Group, LLC 76,879 71,590 -6.88 524 378 -27.86
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 0 24,100 0 127
2018-04-18 13F-HR/A FNY Managed Accounts LLC Call 205 0 -100.00 1 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 12,304 14,527 18.07 84 77 -8.33
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 86,046 223,435 159.67 586 1,180 101.37
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 86,839 29,937 -65.53 591 158 -73.27
2018-05-15 13F-HR Advisor Group, Inc. 3,745 3,764 0.51 26 20 -23.08
2018-05-10 13F-HR BESSEMER GROUP INC 88 0
2018-05-11 13F-HR Cutler Group LP 9,253 3,400 -63.26 63 17 -73.02
2018-05-11 13F-HR Cutler Group LP Put 800 8,300 937.50 0 18
2018-05-08 13F-HR Parallel Advisors, LLC 2,572 2,572 0.00 18 14 -22.22
2018-04-24 13F-HR Rehmann Capital Advisory Group 72 0
2018-04-23 13F-HR Advisory Services Network, LLC 4 4 0.00 0 0
2018-05-14 13F-HR RMB Capital Management, LLC 28,006 0 -100.00 191 0 -100.00
2018-04-06 13F-HR Eqis Capital Management, Inc. 116,495 115,786 -0.61 793 611 -22.95
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 137,164 148,762 8.46 867 738 -14.88
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 20,929 0 -100.00 143 0 -100.00
2018-04-27 13F-HR Chicago Partners Investment Group LLC 2,685 2,685 0.00 18 14 -22.22
2018-04-26 13F-HR SIMPLEX TRADING, LLC 24,196 0 -100.00 164 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 43,400 229
2018-05-11 13F-HR CITADEL ADVISORS LLC 29,937 158
2018-05-09 13F-HR BlackRock Inc. 218,307 215,496 -1.29 1,486 1,136 -23.55
2018-05-15 13F-HR GV Financial Advisors 500 3
2018-05-08 13F-HR US BANCORP \DE\ 999 999 0.00 7 5 -28.57
2018-05-15 13F-HR SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 109,681 579
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 446,929 198,045 -55.69 3,044 1,046 -65.64
2018-05-10 13F-HR JP Morgan Chase & Co 317,537 446,603 40.65 2,162 2,358 9.07
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 101,452 49,695 -51.02 691 262 -62.08
2017-02-10 13F-HR BlackRock Fund Advisors 10,239 20,456 99.79 65 101 55.38
2018-05-15 13F-HR DEUTSCHE BANK AG\ 165,483 203,009 22.68 1,126 1,071 -4.88
2018-05-15 13F-HR JANE STREET GROUP, LLC 15,996 0 -100.00 109 0 -100.00
2018-05-09 13F-HR NORTHERN TRUST CORP 34,040 38,644 13.53 231 204 -11.69
2018-04-26 13F-HR OLD POINT TRUST & FINANCIAL SERVICES N A 30,000 0 -100.00 204 0 -100.00
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 139,090 186,390 34.01 947 984 3.91
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 137,400 168,300 22.49 936 889 -5.02
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 30,000 30,000 0.00 204 158 -22.55
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 45,800 43,400 -5.24 312 229 -26.60
2018-05-16 13F-HR Private Capital Group, Llc 69 0
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 21,800 21,800 0.00 148 115 -22.30
2018-05-15 13F-HR Walleye Trading LLC 0 14,900 0 79

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Very Little Can Be Gleaned From Xinyuan's Latest Financial Reports

2018-06-04 seekingalpha
For the last few years, a number of pundits have carefully reviewed Xinyuan’s (NYSE:XIN) quarterly and annual reports and offered opinions on them. For the most part, the reports have been positive, emphasizing the fact that by normal financial standards, the company is undervalued. Their latest annual and quarterly reports just came out. And sadly, it is difficult to draw meaningful conclusions about. (5-1)

Xinyuan Real Estate Co., Ltd (XIN) CEO Lizhou Zhang on Q1 2018 Results - Earnings Call Transcript

2018-05-30 seekingalpha
Xinyuan Real Estate Co., Ltd. (NYSE:XIN) Q1 2018 Earnings Conference Call May 30, 2018 8:00 AM ET (5-0)

How To Profit From Chinese Companies' Going-Home Frenzy

2018-04-10 seekingalpha
Among big caps, Alibaba is likely to be the first one to trade CDRs of its shares in China. (133-0)

CUSIP: 98417P105